ACORN ENERGY, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ACORN ENERGY, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $4.35M | Mar 26, 2018 |
| FY2017 | Dec 31, 2016 | $8.66M | Mar 26, 2018 |
| FY2016 | Dec 31, 2015 | $16.55M | Mar 29, 2017 |
| FY2015 | Dec 31, 2014 | $19.56M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $20.29M | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $17.86M | Mar 17, 2014 |
| FY2013 | Dec 31, 2011 | $17.54M | Mar 17, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.48M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $10.99M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $8.06M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $7.00M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $6.78M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $5.92M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $5.49M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $5.09M | Mar 25, 2020 |
| FY2018 | Dec 31, 2017 | $4.35M | Mar 27, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $5.83M | Mar 17, 2014 |
| FY2013 | Sep 30, 2013 | $4.98M | Mar 17, 2014 |
| FY2013 | Jun 30, 2013 | $5.23M | Mar 17, 2014 |
| FY2013 | Mar 31, 2013 | $5.72M | Mar 17, 2014 |
| FY2013 | Dec 31, 2012 | $4.80M | Mar 17, 2014 |
| FY2013 | Sep 30, 2012 | $4.71M | Mar 17, 2014 |
| FY2013 | Jun 30, 2012 | $5.73M | Mar 17, 2014 |
| FY2013 | Mar 31, 2012 | $4.18M | Mar 17, 2014 |
| FY2012 | Dec 31, 2011 | $6.68M | Mar 18, 2013 |
| FY2012 | Sep 30, 2011 | $5.05M | Mar 18, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.82M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $8.00M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $6.00M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $5.07M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $4.90M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $4.13M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $3.59M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $3.12M | Mar 25, 2020 |
| FY2018 | Dec 31, 2017 | $2.45M | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | $3.53M | Mar 26, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.51M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $6.29M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $119.0K | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | ($633.0K) | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | ($21.0K) | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $69.0K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($618.0K) | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | ($2.00M) | Mar 25, 2020 |
| FY2018 | Dec 31, 2017 | ($1.17M) | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | $145.0K | Mar 26, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.99M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $1.94M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $74.0K | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | ($629.0K) | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | ($8.0K) | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | ($310.0K) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($699.0K) | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | ($1.41M) | Mar 25, 2020 |
| FY2018 | Dec 31, 2017 | ($1.91M) | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | ($3.05M) | Mar 26, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.09M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $1.01M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $875.0K | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $845.0K | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $739.0K | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $619.0K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $559.0K | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $542.0K | Mar 25, 2020 |
| FY2018 | Dec 31, 2017 | $518.0K | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | $927.0K | Mar 26, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.73M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $5.05M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $5.06M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $4.80M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $4.17M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $3.82M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $3.73M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $3.99M | Mar 25, 2020 |
| FY2018 | Dec 31, 2017 | $3.84M | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | $5.65M | Mar 26, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.09M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $905.0K | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $72.0K | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $31.0K | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $132.0K | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $464.0K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($1.22M) | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | ($2.42M) | Mar 25, 2020 |
| FY2018 | Dec 31, 2017 | ($1.68M) | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | ($4.52M) | Mar 26, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2016 | $33.0K | Mar 26, 2018 |
| FY2016 | Dec 31, 2015 | $159.0K | Mar 29, 2017 |
| FY2015 | Dec 31, 2014 | $393.0K | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $1.47M | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $684.0K | Mar 17, 2014 |
| FY2013 | Dec 31, 2011 | $502.0K | Mar 17, 2014 |
| FY2012 | Dec 31, 2010 | ($237.0K) | Mar 18, 2013 |
| FY2011 | Dec 31, 2009 | $240.0K | Mar 15, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.33M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $10.60M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $5.45M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $5.98M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $6.04M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $5.20M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $4.98M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $3.92M | Mar 25, 2020 |
| FY2018 | Dec 31, 2017 | $9.22M | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | $9.24M | Mar 26, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.02M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $5.02M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $6.28M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $7.00M | Mar 7, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.25M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $5.54M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | ($838.0K) | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | ($1.02M) | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | ($469.0K) | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | ($523.0K) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($646.0K) | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | ($1.34M) | Mar 25, 2020 |
| FY2018 | Dec 31, 2017 | $471.0K | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | $1.33M | Mar 26, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2015 | $516.0K | Mar 29, 2017 |
| FY2015 | Dec 31, 2014 | $1.03M | Mar 30, 2016 |
| FY2015 | Dec 31, 2013 | $3.03M | Mar 30, 2016 |
| FY2013 | Dec 31, 2012 | $6.63M | Mar 17, 2014 |
| FY2013 | Dec 31, 2011 | $4.64M | Mar 17, 2014 |
| FY2012 | Dec 31, 2010 | $4.68M | Mar 18, 2013 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($92.34M) | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | ($94.85M) | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | ($101.15M) | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | ($101.27M) | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | ($100.63M) | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | ($100.61M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($100.68M) | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | ($100.06M) | Mar 25, 2020 |
| FY2018 | Dec 31, 2017 | ($98.22M) | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | ($97.05M) | Mar 26, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.45M | Mar 5, 2026 |
| FY2024 | Dec 31, 2024 | $2.33M | Mar 6, 2025 |
| FY2023 | Dec 31, 2023 | $1.45M | Mar 7, 2024 |
| FY2022 | Dec 31, 2022 | $1.45M | Mar 16, 2023 |
| FY2022 | Dec 31, 2021 | $1.72M | Mar 16, 2023 |
| FY2021 | Dec 31, 2020 | $2.06M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $1.25M | Mar 16, 2021 |
| FY2020 | Dec 31, 2018 | $973.0K | Mar 16, 2021 |
| FY2019 | Dec 31, 2017 | $481.0K | Mar 25, 2020 |
| FY2018 | Dec 31, 2016 | $241.0K | Mar 27, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $0 | Mar 17, 2014 |
| FY2012 | Dec 31, 2012 | $143.0K | Mar 18, 2013 |
| FY2012 | Dec 31, 2011 | $274.0K | Mar 18, 2013 |
| FY2012 | Dec 31, 2009 | $530.0K | Mar 18, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 16, 2023 |
| FY2013 | Dec 31, 2013 | (1) | Mar 17, 2014 |
| FY2012 | Dec 31, 2012 | 0 | Mar 18, 2013 |
| FY2012 | Sep 30, 2012 | 0 | Mar 18, 2013 |
| FY2012 | Jun 30, 2012 | 0 | Mar 18, 2013 |
| FY2012 | Mar 31, 2012 | 0 | Mar 18, 2013 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 7, 2024 |
| FY2013 | Dec 31, 2013 | (1) | Mar 17, 2014 |
| FY2013 | Dec 31, 2012 | 0 | Mar 17, 2014 |
| FY2012 | Dec 31, 2011 | 0 | Mar 18, 2013 |
| FY2012 | Sep 30, 2011 | 2 | Mar 18, 2013 |
| FY2012 | Jun 30, 2011 | 0 | Mar 18, 2013 |
| FY2012 | Mar 31, 2011 | 0 | Mar 18, 2013 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2.50M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | 2.49M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | 2.48M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | 2.48M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | 39.69M | Mar 16, 2023 |
| FY2020 | Dec 31, 2020 | 39.69M | Mar 16, 2021 |
| FY2019 | Dec 31, 2019 | 39.59M | Mar 25, 2020 |
| FY2019 | Dec 31, 2018 | 29.56M | Mar 25, 2020 |
| FY2017 | Dec 31, 2017 | 29.50M | Mar 26, 2018 |
| FY2016 | Dec 31, 2016 | 29.32M | Mar 29, 2017 |